Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture.

Literature DB >> 16043839

Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture.

David H Abramson¹.

Abstract

Entities: Disease

Mesh：

Year: 2005 PMID： 16043839 DOI： 10.1167/iovs.04-1462

Source DB: PubMed Journal: Invest Ophthalmol Vis Sci ISSN： 0146-0404 Impact factor: 4.799

Keyword Cloud
Cited

× No keyword cloud information.

43 in total

1. Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy.

Authors: Steven M Nguyen; Julian Sison; Marjorie Jones; Jesse L Berry; Jonathan W Kim; A Linn Murphree; Vanessa Salinas; Arthur J Olch; Eric L Chang; Kenneth K Wong
Journal: Int J Radiat Oncol Biol Phys Date: 2018-12-08 Impact factor: 7.038

2. Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

Authors: Hans E Grossniklaus
Journal: Am J Ophthalmol Date: 2014-07-24 Impact factor: 5.258

3. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.

Authors: Roshan V Sethi; Helen A Shih; Beow Y Yeap; Kent W Mouw; Robert Petersen; David Y Kim; John E Munzenrider; Eric Grabowski; Carlos Rodriguez-Galindo; Torunn I Yock; Nancy J Tarbell; Karen J Marcus; Shizuo Mukai; Shannon M MacDonald
Journal: Cancer Date: 2013-10-02 Impact factor: 6.860

4. Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivors.

Authors: Pooja Bhagia; Agnes Basas Colanta; David H Abramson; Diane L Carlson; Ruth A Kleinerman; Dennis Kraus; Ira J Dunkel
Journal: Pediatr Blood Cancer Date: 2011-05-05 Impact factor: 3.167

5. Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma.

Authors: Aman Khurana; Christina A Eisenhut; Wenshuai Wan; Katayoon B Ebrahimi; Chirag Patel; Joan M O'Brien; Kristen Yeom; Heike E Daldrup-Link
Journal: Eur Radiol Date: 2012-11-18 Impact factor: 5.315

6. Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.

Authors: Yolanda Piña; Christina Decatur; Timothy G Murray; Samuel K Houston; Milena Lopez-Cavalcante; Eleut Hernandez; Magda Celdran; Nikesh Shah; William Feuer; Theodore Lampidis
Journal: Invest Ophthalmol Vis Sci Date: 2012-02-27 Impact factor: 4.799

Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture.

1. Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy.

2. Retinoblastoma. Fifty years of progress. The LXXI Edward Jackson Memorial Lecture.

3. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.

4. Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivors.

5. Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma.

6. Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.

7. Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors.

8. Long non-coding RNA BANCR regulates growth and metastasis and is associated with poor prognosis in retinoblastoma.

9. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.

10. "Retinoblastoma survival disparity": The expanding horizon in developing countries.